Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Atrion Corporation ATRI NASDAQ

NASDAQ Global Select • Healthcare • Medical - Instruments & Supplies • US • USD

SharesGrow Score
52/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Atrion Corporation (ATRI) has a consensus analyst rating of Sell, based on 1 analyst covering the stock. Of those, 0 recommend buying, 0 recommend holding, and 1 recommend selling.

Analyst Consensus — ATRI

Sell
Strong Buy
0
Buy
0
Hold
0
Sell
1
Strong Sell
0
1 analysts
Price Targets

No price target data available.

People Also View

COO
COO
The Cooper Companies, Inc.
$71.61
-0.13%
 ATR
ATR
AptarGroup, Inc.
$131.01
-0.83%
 NVST
NVST
Envista Holdings Corp
$27.38
+1.75%
 MMSI
MMSI
Merit Medical Systems, Inc.
$70.54
-0.04%
 ICUI
ICUI
ICU Medical, Inc.
$127.85
-1.14%
 HAE
HAE
Haemonetics Corporation
$60.48
+2.04%
 ATRC
ATRC
AtriCure, Inc.
$29.40
+2.58%
 ANGO
ANGO
AngioDynamics, Inc.
$10.47
+2.25%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message